Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madeline Gunawardena

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
AAPS Open|July 6, 2026
Machine learning guided optimization of an oral microemulsion system: a Bayesian optimization approachMadeline Gunawardena, Bao Chau, Hayden Nothacker, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Machine Learning Guided Optimization of an Oral Microemulsion System: A Bayesian Optimization ApproachMadeline Gunawardena, Bao Chau, Hayden Nothacker, et al.
Biomolecules|August 28, 2025
Oral Pharmacokinetic Evaluation of a Microemulsion-Based Delivery System for Novel A190 ProdrugsSagun Poudel, Chaolong Qin, Rudra Pangeni, et al.
Pharmacological Research|March 22, 2026
MDA-9/Syntenin small molecule inhibitor IVMT-Rx-4 blocks prostate cancer bone metastasisSantanu Maji, Amit Kumar, Padmanabhan Mannangatti, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
AAPS Open|July 6, 2026
Machine learning guided optimization of an oral microemulsion system: a Bayesian optimization approachMadeline Gunawardena, Bao Chau, Hayden Nothacker, et al.
Biorxiv : the Preprint Server for Biology|February 12, 2026
Machine Learning Guided Optimization of an Oral Microemulsion System: A Bayesian Optimization ApproachMadeline Gunawardena, Bao Chau, Hayden Nothacker, et al.
Biomolecules|August 28, 2025
Oral Pharmacokinetic Evaluation of a Microemulsion-Based Delivery System for Novel A190 ProdrugsSagun Poudel, Chaolong Qin, Rudra Pangeni, et al.
Pharmacological Research|March 22, 2026
MDA-9/Syntenin small molecule inhibitor IVMT-Rx-4 blocks prostate cancer bone metastasisSantanu Maji, Amit Kumar, Padmanabhan Mannangatti, et al.
Pageof 1